You are here

  • Home
  • Archive
  • Volume 31, Issue 5
  • Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

Article metrics

Article menu
Download PDFPDF
Original research
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

 

Online download statistics by month:

Online download statistics by month: April 2023 to April 2025

AbstractFullPdf
Apr 20231223913
May 2023270786
Jun 2023308843
Jul 2023206221
Aug 202317943
Sep 202317511
Oct 202317412
Nov 202314822
Dec 202322123
Jan 202414213
Feb 20249422
Mar 202411465
Apr 20249011
May 20247933
Jun 20248011
Jul 20246622
Aug 202445163
Sep 202485375
Oct 2024553128
Nov 202423823
Dec 202424450
Jan 202530000
Feb 20254532
Mar 20251475
Apr 2025322
Total133439379